Adil Rasheed

929 total citations
21 papers, 489 citations indexed

About

Adil Rasheed is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Adil Rasheed has authored 21 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Adil Rasheed's work include Cholesterol and Lipid Metabolism (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Phagocytosis and Immune Regulation (4 papers). Adil Rasheed is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Phagocytosis and Immune Regulation (4 papers). Adil Rasheed collaborates with scholars based in Canada, United States and Türkiye. Adil Rasheed's co-authors include Katey J. Rayner, Carolyn L. Cummins, Michèle Geoffrion, My-Anh Nguyen, Hailey Wyatt, Leah C. Susser, Anne‐Claire Duchez, Suresh Gadde, Marceline Côté and Mireille Ouimet and has published in prestigious journals such as Cell, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Adil Rasheed

20 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adil Rasheed Canada 9 232 159 116 105 59 21 489
Jari P. Lappalainen Finland 9 276 1.2× 128 0.8× 81 0.7× 70 0.7× 34 0.6× 9 514
Hendrika A. B. Peters Netherlands 13 246 1.1× 151 0.9× 75 0.6× 119 1.1× 67 1.1× 27 502
Zihan Ma China 9 200 0.9× 87 0.5× 57 0.5× 70 0.7× 30 0.5× 13 438
Yue Wen China 11 299 1.3× 114 0.7× 112 1.0× 106 1.0× 192 3.3× 20 655
Gwon‐Soo Jung South Korea 15 229 1.0× 71 0.4× 82 0.7× 69 0.7× 93 1.6× 27 591
Weihua Bian China 12 349 1.5× 62 0.4× 86 0.7× 195 1.9× 56 0.9× 27 523
Heike Meýborg Germany 16 233 1.0× 134 0.8× 90 0.8× 128 1.2× 64 1.1× 31 574
Yaowalak U‐pratya Thailand 16 414 1.8× 63 0.4× 110 0.9× 63 0.6× 67 1.1× 47 747
Alyssa Torres United States 6 266 1.1× 92 0.6× 82 0.7× 96 0.9× 88 1.5× 7 691

Countries citing papers authored by Adil Rasheed

Since Specialization
Citations

This map shows the geographic impact of Adil Rasheed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adil Rasheed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adil Rasheed more than expected).

Fields of papers citing papers by Adil Rasheed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adil Rasheed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adil Rasheed. The network helps show where Adil Rasheed may publish in the future.

Co-authorship network of co-authors of Adil Rasheed

This figure shows the co-authorship network connecting the top 25 collaborators of Adil Rasheed. A scholar is included among the top collaborators of Adil Rasheed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adil Rasheed. Adil Rasheed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Steinbeck, J., et al.. (2025). Dysregulated Lipid Metabolism as a Central Driver of Atherosclerotic Plaque Pathology. 2(4). 17–17. 1 indexed citations
3.
Boucher, Dominique, Sabrina Robichaud, Adil Rasheed, et al.. (2025). Age-Related Impairments in Immune Cell Efferocytosis and Autophagy Hinder Atherosclerosis Regression. Arteriosclerosis Thrombosis and Vascular Biology. 45(4). 481–495. 8 indexed citations
4.
Zierath, Juleen R., Jolanda van der Velden, Ali Javaheri, et al.. (2024). Translating metabolic and cardiovascular research into effective treatments: What’s next?. Cell. 187(15). 3880–3884. 1 indexed citations
5.
Rasheed, Adil, Sabrina Robichaud, My-Anh Nguyen, et al.. (2024). Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche. Nature Cardiovascular Research. 3(5). 594–611. 2 indexed citations
6.
Nguyen, My-Anh, Huy‐Dung Hoang, Adil Rasheed, et al.. (2022). miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages. Circulation Research. 131(1). 42–58. 42 indexed citations
7.
Jung, Richard G., Anne‐Claire Duchez, Trevor Simard, et al.. (2022). Plasminogen Activator Inhibitor-1–Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype. JACC Basic to Translational Science. 7(10). 985–997. 2 indexed citations
8.
Rasheed, Adil. (2022). Niche Regulation of Hematopoiesis: The Environment Is “Micro,” but the Influence Is Large. Arteriosclerosis Thrombosis and Vascular Biology. 42(6). 691–699. 7 indexed citations
9.
Robichaud, Sabrina, Adil Rasheed, Lara Gharibeh, et al.. (2022). Autophagy is differentially regulated in leukocyte and nonleukocyte foam cells during atherosclerosis. Atherosclerosis. 355. 75–76. 1 indexed citations
10.
Rasheed, Adil & Katey J. Rayner. (2021). Macrophage Responses to Environmental Stimuli During Homeostasis and Disease. Endocrine Reviews. 42(4). 407–435. 47 indexed citations
11.
Simard, Trevor, Pouya Motazedian, Pietro Di Santo, et al.. (2021). Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis. Journal of Cardiovascular Pharmacology. 77(4). 450–457. 1 indexed citations
12.
Ouimet, Mireille, Sabrina Robichaud, Adil Rasheed, et al.. (2021). IMPAIRED AUTOPHAGY IN ARTERIAL FOAM CELL POPULATIONS DURING ATHEROSCLEROSIS. Canadian Journal of Cardiology. 37(10). S24–S24. 1 indexed citations
13.
Rasheed, Adil, Sabrina Robichaud, My-Anh Nguyen, et al.. (2020). Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 40(5). 1155–1167. 52 indexed citations
14.
Rasheed, Adil, Ricky Tsai, Richard G. Jung, et al.. (2020). The secretome of liver X receptor agonist-treated early outgrowth cells decreases atherosclerosis in Ldlr −/− mice. Stem Cells Translational Medicine. 10(3). 479–491. 8 indexed citations
15.
Nguyen, My-Anh, Hailey Wyatt, Leah C. Susser, et al.. (2019). Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo. ACS Nano. 13(6). 6491–6505. 123 indexed citations
16.
Rasheed, Adil, Michèle Geoffrion, My-Anh Nguyen, Richard Lee, & Katey J. Rayner. (2018). Whole Body Knockdown of Mixed Lineage Kinase Domain-like Protein Decreases Circulating Lipids but Does Not Protect Against Atherosclerosis. Atherosclerosis Supplements. 32. 100–100. 1 indexed citations
17.
Rasheed, Adil & Carolyn L. Cummins. (2018). Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis. International Journal of Molecular Sciences. 19(8). 2307–2307. 33 indexed citations
18.
Ahmed, Shaimaa, Alvin Gomez, Laura Tamblyn, et al.. (2015). Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality. Journal of Biological Chemistry. 290(27). 16824–16840. 59 indexed citations
19.
Patel, Monika, Xiaoxin X. Wang, Lilia Magomedova, et al.. (2013). Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice. Diabetologia. 57(2). 435–446. 35 indexed citations
20.
Hazra, Sugata, Adil Rasheed, Ashay D. Bhatwadekar, et al.. (2012). Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes. Diabetes. 61(12). 3270–3279. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026